Comparison of the Efficacy of Morning versus Evening Administration of Olmesartan in Uncomplicated Essential Hypertension

References

• Chobanian A V, Bakris G L, Black H R, Cushman W C, Green L A, Izzo J L, Jones D W, Materson B J, Oparil S, Wright J T, Rocella E J. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003; 289: 2560–2571, and the National High Blood Pressure Education Coordinating Committee
   PubMed Web of Science ®Google Scholar
• Chrysant S G, Marbury T C, Robinson T D. Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild‐to‐moderate hypertension. J. Hum. Hypertens. 2003; 17: 425–432
   PubMed Web of Science ®Google Scholar
• Fernández J R, Hermida R C. Inferential statistical method for analysis of nonsinusoidal hybrid time series with unequidistant observations. Chronobiol. Int. 1998; 15: 191–204
   PubMed Web of Science ®Google Scholar
• Fernández J R, Mojón A, Hermida R C. Comparison of parameters from rhythmometric models with multiple components on hybrid data. Chronobiol. Int. 2004; 21: 469–484
   PubMed Web of Science ®Google Scholar
• Guidelines Committee. European Society of Hypertension—European Society of Cardiology guidelines for the management of arterial hypertension. J. Hypertens. 2003; 21: 1011–1053
   PubMed Web of Science ®Google Scholar
• Hermida R C, Smolensky M H. Chronotherapy of hypertension. Curr. Opin. Nephrol. Hypertens. 2004; 13: 501–505
   PubMed Web of Science ®Google Scholar
• Hermida R C, Ayala D E, Fernández J R, Mojón A, Alonso I, Calvo C. Modeling the circadian variability of ambulatorily monitored blood pressure by multiple‐component analysis. Chronobiol. Int. 2002a; 19: 461–481
   PubMed Web of Science ®Google Scholar
• Hermida R C, Calvo C, Ayala D E, Mojón A, López J E. Relationship between physical activity and blood pressure in dipper and nondipper hypertensive patients. J. Hypertens. 2002b; 20: 1097–1104
   PubMed Web of Science ®Google Scholar
• Hermida R C, Calvo C, Ayala D E, Domínguez M J, Covelo M, Fernández J R, Mojón A, López J E. Administration time‐dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects. Hypertension 2003; 42: 283–290
   PubMed Web of Science ®Google Scholar
• Hermida R C, Ayala D E, Calvo C. Administration time‐dependent effects of antihypertensive treatment on the circadian pattern of blood pressure. Curr. Opin. Nephrol. Hypertens. 2005a; 14: 453–459
   PubMed Web of Science ®Google Scholar
• Hermida R C, Calvo C, Ayala D E, Fernández J R, Covelo M, Mojón A, López J E. Treatment of non‐dipper hypertension with bedtime administration of valsartan. J. Hypertens. 2005b; 23: 1913–1922
   PubMed Web of Science ®Google Scholar
• Hermida R C, Calvo C, Ayala D E, Mojón A, Rodríguez M, Chayán L, López J E, Fontao M J, Soler R, Fernández J R. Administration time‐dependent effects of valsartan on ambulatory blood pressure in elderly hypertensive subjects. Chronobiol. Int. 2005c; 22: 755–776
   PubMed Web of Science ®Google Scholar
• Labrecque G, Beauchamp D. Rhythms and pharmacokinetics. Chronotherapeutics, P Redfern. Pharamceutical Press, London 2003; 75–110
   Google Scholar
• Laeis P, Puchler K, Kirch W. The pharmacokinetic and metabolic profile of olmesartan medoxomil limits the risk of clinically relevant drug interaction. J. Hypertens. 2001; 19: S21–S32
   PubMed Web of Science ®Google Scholar
• Lemmer B. Cardiovascular chronobiology and chronopharmacology. Importance of timing of dosing. Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics, W.B White. Humana Press, Totowa, NJ 2000; 255–271
   Google Scholar
• Neutel J M. Clinical studies of CS‐866, the newest angiotensin II receptor antagonist. Am. J. Cardiol. 2001; 87: 37C–43C
   PubMed Web of Science ®Google Scholar
• Neutel J M, Elliot W J, Izzo J L, Chen C L, Masonson H N. Antihypertensive efficacy of olmesartan medoxomil, a new angiotensin II receptor antagonist, as assessed by ambulatory blood pressure measurements. J. Clin. Hypertens. (Greenwich) 2002; 4: 325–331
   PubMedGoogle Scholar
• O'Brien E, Staessen J. Normotension and hypertension as defined by 24‐hour ambulatory blood pressure monitoring. Blood Press. 1995; 4: 266–282
   PubMedGoogle Scholar
• O'Brien A, Asmar R, Beilin L, Imai Y, Mallion J M, Mancia G, Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou G, Verdecchia P. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J. Hypertens. 2003; 21: 821–848, on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring
   PubMed Web of Science ®Google Scholar
• Oparil S, Silfani T N, Walker J F. Role of angiotensin receptor blockers as monotherapy in reaching blood pressure goals. Am. J. Hypertens. 2005; 18(2Pt1)287–294
   PubMedGoogle Scholar
• Pickering T G, Hall J E, Appel L J, Falkner B E, Graves J, Hill M N, Jones D W, Kurtz T, Sheps S G, Roccella E J. Recommendations for blood pressure measurement in humans and experimental animals, Part 1: Blood pressure measurement in humans. Hypertension 2005; 45: 142–161
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Smolensky M H. Circadian rhythm and environmental determinants of blood pressure regulation in normal and hypertensive conditions. Blood Pressure Monitoring in Cardiovascular Medicine and Therapeuticss, W.B White. Humana Press, Totowa, NJ 2000; 79–118
   Google Scholar
• Smolensky M H, Hermida R, Portaluppi F, Haus E, Reinberg A. Chronotherapeutics in the treatment of hypertension. Hypertension: A Companion to Brenner and Rector's The Kidney2nd ed., S Oparil, MA Weber. Elsevier Saunders, Philadelphia 2005; 530–542
   Google Scholar
• Touitou Y, Smolensky M H, Portaluppi F. Ethics, standards, and procedures of animal and human chronobiology research. Chronobiol. Int. 2006; 23: 1083–1096
   PubMed Web of Science ®Google Scholar
• Witte K, Lemmer B. Rhythms and pharmacodynamics. Chronotherapeutics, P Redfern. Pharamceutical Press, London, 111–126
   Google Scholar